CAR NK Cell Therapy for T Follicular Helper Cells
Cecile King
Cell Reports Medicine · 2020
doi:10.1016/j.xcrm.2020.100009 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
T follicular helper (TFH) cells are associated with the development of both autoimmune disease and T cell malignancies. In this issue, Reighard et al.,1 describe the design of PD-L1 chimeric antigen receptor (CAR) NK cells that effectively target and eliminate TFH cells.
Abstract licence: CC BY-NC
Cited by papers we hold2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.